Prime Medicine, Inc. (PRME)

NASDAQ: PRME · Real-Time Price · USD

2.420

-0.230 (-8.68%)

At close: Jun 27, 2025, 4:00 PM

2.400

-0.020 (-0.83%)

After-hours: Jun 27, 2025, 7:58 PM EDT

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '20 Dec 31, 2020
Genetic Therapies	2.98M	Log In
Genetic Therapies Growth	-42.74%	Log In

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '20 Dec 31, 2020
United States	2.98M	Log In
United States Growth	-42.74%	Log In